CD133+/ABCC5+ 宫癌细胞表现出癌症干细胞的特性
Lin He1, Hengjun Qian2, Ayinuer Seyiti3
1Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi, Xinjiang, 830011, PR China.
Heliyon
|September 19, 2024
概括
这项研究确定了CD133+ABCC5+作为宫癌干细胞的新型标记物,提供了克服宫癌治疗中帕克利塔塞尔耐药性的新策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 宫癌对健康构成重大挑战,因为帕克利塔克塞尔耐药性限制了治疗的有效性.
- 癌症干细胞 (CSCs) 与治疗耐药性和瘤复发有关.
- 识别CSC标志物对于开发向疗法至关重要.
研究的目的:
- 调查Forkhead盒子M1 (FOXM1) 和ATP结合盒子子子家族C成员5 (ABCC5) 在抗帕克利塔塞尔的宫癌中之间的相关性.
- 为了识别新的宫癌干细胞标记物.
- 为克服帕克利塔克塞尔化学抵抗提供见解.
主要方法:
- 开发出耐帕克利塔塞尔的Hela细胞 (Hela/Taxol).
- 评估生物特性 (增殖,迁移,亡) 和干细胞标记物,使用流细胞计.
- 排序了CD133+ABCC5+细胞,并进行了球形形成试验和Sox2表达的Western blot.
主要成果:
- 黑拉/塔克索细胞表现出增强的增殖,迁移和入侵,并减少了亡.
- 在Hela/Taxol细胞中观察到CD44+,CD24+,ABCC5+,FOXM1+和CD133+标记物的比例明显更高.
- 排序的CD133+ABCC5+细胞表现出球形形成的增加和Sox2表达的增加,表明增强的干性.
结论:
- 抗帕克利塔塞尔的Hela细胞显示瘤干细胞的增加.
- CD133+ABCC5+作为宫癌干细胞的潜在新型标记物出现.
- 这一发现可能为针对宫癌的新疗法策略铺平了道路.
关键词:
ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5ABCC5C5C宫癌是发生在宫癌的原因之一.在FOXM1中,我们可以看到FOXM1.帕克利塔克塞尔 (Paclitaxel) 是一种药物.相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
3.4K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.4K
Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


